Impact of Noncovalent Sulfur–Fluorine Interaction Position on Properties,Structures, and Photovoltaic Performance in Naphthobisthiadiazole‐Based Semiconducting Polymers

Controlling the energetics and backbone order of semiconducting polymers is essential for the performance improvement of polymer‐based solar cells. The use of fluorine as the substituent for the backbone is known to effectively deepen the molecular orbital energy levels and coplanarize the backbone by noncovalent interactions with sulfur of the thiophene ring. In this work, novel semiconducting polymers are designed and synthesized based on difluoronaphthobisthiadiazole (FNTz) as a new family of naphthobisthiadiazole (NTz)–quaterthiophene copolymer systems, which are one of the highest performing polymers in solar cells. The effect of the fluorination position on the energetics and backbone order is systematically studied. It is found that the dependence of the solar cell fill factor on the active layer thickness is very sensitive to the fluorination position. It is thus further investigated and discussed how the structural features of the polymers influence the photovoltaic parameters as well as the diode characteristics and bimolecular recombination. Further, the polymer with fluorine on both the naphthobisthiadiazole and quaterthiophene moieties exhibits a quite high power conversion efficiency of 10.8% in solar cells in combination with a fullerene. It is believed that the results would offer new insights into the development of semiconducting polymers.     

Synthesis and antitumour evaluation of novel 2-phenylbenzimidazoles

A new series of fluorinated and non-fluorinated 2-phenylbenzimidazoles bearing oxygenated substituents on the phenyl ring has been synthesized. Synthesis of the new series was based on our previous discovery of 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610) as a potent and selective antitumour agent in vitro (sub-nanomolar GI₅₀ in sensitive human cancer cell lines), but with poor aqueous solubility and lack of a definitive cellular target limiting further development. In this study we test the hypothesis that 2-phenylbenzimidazoles with similar substitution patterns to PMX 610 would retain potent antitumour activity but with potentially superior pharmaceutical properties. In general the new compounds were less active than the former benzothiazole series in vitro when tested against the breast cancer cell lines MCF-7 and MDA 468; however the two most active compounds in the present series (3j and 3k) exhibit low micromolar GI₅₀ values in both cell lines and provide the opportunity for further chemical derivatization with a view to target identification.     

Synthesis of 2,3- or 1,2-unsaturated derivatives of 2-deoxy-2-trifluoromethylhexopyranoses

The attempted conversion, by treatment with CsF/TBFA in MeCN, of acetylated derivatives of 2-chlorodifluoromethyl-2-deoxyhexopyranoses into their corresponding 2-trifluoromethyl derivatives was always accompanied by an elimination reaction. Thus, representative educts with the D-gluco- and D-manno-configuration gave derivatives of 2,3-dideoxy-2-trifluoromethyl-D-erythro-hex-2-enopyranose and 1,5-anhydro-2-deoxy-2-trifluoromethyl-d-arabino-hex-1-enitol, respectively. X-ray analyses are given for 1,3,4,6-tetra-O-acetyl-2-chlorodifluoromethyl-2-deoxy-alpha-D-mannopyranose and 4,6-di-O-acetyl-2,3-dideoxy-2-trifluoromethyl-alpha-D-erythro-hex-2-enopyranose.     

Two-step regio- and stereoselective syntheses of [19F]- and [18F]-2-deoxy-2-(R)-fluoro-beta-D-allose

Replacement of specific hydroxyl groups by fluorine in carbohydrates is an ongoing challenge from chemical, biological, and pharmaceutical points of view. A rapid and efficient two-step, regio- and stereoselective synthesis of 2-deoxy-2-(R)-fluoro-beta-d-allose (2-(R)-fluoro-2-deoxy-beta-d-allose; 2-FDbetaA), a fluorinated analogue of the rare sugar, d-allose, is described. TAG (3,4,6-tri-O-acetyl-1,5-anhydro-2-deoxy-d-arabino-hex-1-enitol or 3,4,6-tri-O-acetyl-d-glucal), was fluorinated in anhydrous HF with dilute F(2) in a Ne/He mixture or with CH(3)COOF at -60 degrees C. The fluorinated intermediate was hydrolyzed in 1N HCl and the hydrolysis product was purified by liquid chromatography and characterized by 1D (1)H, (13)C, and (19)F NMR spectroscopy as well as 2D NMR spectroscopy and mass spectrometry. In addition, (18)F-labeled 2-deoxy-2-(R)-fluoro-beta-d-allose (2-[(18)F]FDbetaA) was synthesized for the first time, with an overall decay-corrected radiochemical yield of 33+/-3% with respect to [(18)F]F(2), the highest radiochemical yield achieved to date for electrophilic fluorination of TAG. The rapid and high radiochemical yield synthesis of 2-[(18)F]FDbetaA has potential as a probe for the bioactivity of d-allose.     

Improved Tandem All‐Polymer Solar Cells Performance by Using Spectrally Matched Subcells

All‐polymer solar cells (all‐PSCs) are attractive as alternatives to fabricate thermally and mechanically stable solar cells, especially with recent improvements in their power conversion efficiency (PCE). In this work, efficient all‐PSCs with near‐infrared response (up to 850 nm) are developed using newly designed regioregular polymer donors with relatively narrow optical gap. These all‐PSCs systems achieve PCEs up to 6.0% after incorporating fluorine into the polymer backbone. More importantly, these polymers exhibit absorbance that is complementary to previously reported wide bandgap polymer donors. Thus, the superior properties of the newly designed polymers afford opportunities to fabricate the first spectrally matched all‐polymer tandem solar cells with high performance. A PCE of 8.3% is then demonstrated which is the highest efficiency so far for all‐polymer tandem solar cells. The design of narrow bandgap polymers provides new directions to enhance the PCE of emerging single‐junction and tandem all polymer solar cells.     

The Introduction of Fluorine and Sulfur Atoms into Benzotriazole‐Based p‐Type Polymers to Match with a Benzotriazole‐Containing n‐Type Small Molecule: “The Same‐Acceptor‐Strategy” to Realize High Open‐Circuit Voltage

“The Same‐Acceptor‐Strategy” (SAS) adopts benzotriazole (BTA)‐based p‐type polymers paired with a new BTA based non‐fullerene acceptor BTA13 to minimize the trade‐off between the open‐circuit voltage (V_OC) and short circuit current (J_SC). The fluorination and sulfuration are introduced to lower the highest occupied molecular orbitals (HOMO) of the polymers. The fluorinated polymer of J52‐F shows the higher power conversion efficiency (PCE) of 8.36% than the analog polymer of J52, benefited from a good balance between an improved V_OC of 1.18 V and a J_SC of 11.55 mA cm^?2. Further adding alkylthio groups on J52‐F, the resulted polymer, J52‐FS, exhibits the highest V_OC of 1.24 V with a decreased energy loss of 0.48 eV, compared with 0.67 eV for J52 and 0.54 eV for J52‐F. However, J52‐FS shows an inferior PCE (3.84%) with a lower J_SC of 6.74 mA cm^?2, because the small ΔE_HOMO between J52‐FS and BTA13 (0.02 eV) gives rise to the inefficient hole transfer and high charge recombination, as well as low carrier mobilities. The results of this study clearly demonstrate that the introduction of different atoms in p‐type polymers is effective to improve the SAS and realize the high (V_OC) and PCE.     

Electrophilic [N—F]+ catalysed asymmetric allylation of (E)‐N,1‐diphenylmethanimine

New efficient catalysts based on electrophilic N‐fluoro quaternary ammonium salts are reported for catalytic allylation of (E)‐N,1‐diphenylmethanimine. The chiral version of the catalyst based on cinchonidine (F‐CD‐BF₄) shows high catalytic activity with approximately 94% ee and TOF (>800 h^?1). The F‐CD‐BF₄ is prepared from cinchonidine and Selectfluor by one‐step transfer fluorination.     

Synthesis of Stable Isotope Labeled Analogs of the Anti-Hepatitis C Virus Nucleotide Prodrugs PSI-7977 and PSI-352938

In order to support bioanalytical LC/MS method development and plasma sample analysis in preclinical and clinical studies of the anti-hepatitis C-virus nucleotides, PSI-7977 and PSI-352938, the corresponding stable isotope labeled forms were prepared. These labeled compounds were prepared by addition reaction of the freshly prepared Grignard reagent ¹³CD₃MgI to the corresponding 2 ′-ketone nucleosides followed by fluorination of the resulting carbinol with DAST. As expected, these 2 ′-C-(trideuterated-¹³C-methyl) nucleotide prodrugs showed similar anti-HCV activity to that of the corresponding unlabeled ones.